Guided Therapeutics (GTHP) Receivables (2010 - 2026)
Guided Therapeutics (GTHP) posted Receivables of $4000.0 for Q4 2025, down 33.33% sequentially from $6000.0 in Q3 2025, and up 33.33% YoY from $3000.0 in Q4 2024.
Guided Therapeutics (GTHP) Receivables (2010 - 2026) Analysis & Trends
Guided Therapeutics has reported Receivables for 16 years, with the latest figure at $4000.0 in Q4 2025.
- Quarterly Receivables rose 33.33% year-over-year to $4000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4000.0 (up 33.33% YoY) and the FY2025 annual result came in at $4000.0, up 33.33% from the prior year.
- Receivables fell to $4000.0 in Q4 2025 per GTHP's latest filing, from $6000.0 in the prior quarter.
- Over five years, Receivables peaked at $502.0 million in Q2 2021 and troughed at $2000.0 in Q1 2025.
- A 5-year average of $41.0 million and a median of $8942.0 in 2023 frame the typical range for Receivables.
- The sharpest annual moves came in 2021 and 2023: Receivables surged 401500.0% in 2021, then tumbled 99.97% in 2023.
- Over 5 years, Receivables stood at $126000.0 in 2021, then slipped by 29.13% to $89296.0 in 2022, then tumbled by 92.16% to $7000.0 in 2023, then sank by 57.14% to $3000.0 in 2024, then jumped by 33.33% to $4000.0 in 2025.
- According to Business Quant data, Receivables over the past three periods registered $4000.0, $6000.0, and $8000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 8.60 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.74 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 6.64 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 3.18 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 955.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 1.28 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 4.66 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 4.12 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.01 Bn |
| 10 | Guided Therapeutics | 26.06 Mn | 26.05 Mn | - | 4,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4,000.00 |
| Dec 31, 2025 | 4,000.00 |
| Sep 30, 2025 | 6,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Sep 30, 2024 | 2,047.00 |
| Jun 30, 2024 | 2,047.00 |
| Mar 31, 2024 | 7,000.00 |
| Dec 31, 2023 | 7,000.00 |
| Sep 30, 2023 | 8,942.00 |
| Jun 30, 2023 | 8,942.00 |
| Mar 31, 2023 | 55,314.00 |
| Dec 31, 2022 | 89,296.00 |
| Sep 30, 2022 | 120,691.00 |
| Jun 30, 2022 | 179,831.00 |
| Mar 31, 2022 | 165.13 Mn |
| Dec 31, 2021 | 126,000.00 |
| Sep 30, 2021 | 149.00 Mn |
| Jun 30, 2021 | 502.00 Mn |